TNF and COVID-19: TNF-a and IFN-γ are also important inflammatory cytokines that provide good targets for cytokine storm control [69], and clinical trials to evaluate these blockers in COVID-19 (ChiCTR-2000030089 and NCT-04324021) are continuing (Blaszczak et al., 2020; Cavalli et al., 2020).